SNCA genetic lowering reveals differential cognitive function of alpha-synuclein dependent on sex (vol 10, 180, 2022)ACTA NEUROPATHOLOGICA COMMUNICATIONSIF5.72024-06-110OA
A Technological and Regulatory Review on Human-Animal Chimera Research: The Current Landscape of Biology, Law, and Public OpinionCELL TRANSPLANTATIONIF3.22023-08-206OAAI
Temporary induction of hypoxic adaptations by preconditioning fails to enhance Schwann cell transplant survival after spinal cord injuryGLIAIF5.12022-12-246PRE
SNCA genetic lowering reveals differential cognitive function of alpha-synuclein dependent on sexACTA NEUROPATHOLOGICA COMMUNICATIONSIF5.72022-12-143OA
Comment on Activation of the Omega-3 Fatty Acid Receptor GPR120 Protects against Focal Cerebral Ischemic Injury by Preventing Inflammation and Apoptosis in MiceJOURNAL OF IMMUNOLOGYIF3.42022-10-011OA
Treatment with hypoxia-mimetics protects cultured rat Schwann cells against oxidative stress-induced cell deathGLIAIF5.12021-05-2110PREAI
The American Public Is Ready to Accept Human-Animal Chimera ResearchSTEM CELL REPORTSIF5.12020-10-0117OAAI
Bidirectional modulation of Alzheimer phenotype by alpha-synuclein in mice and primary neuronsACTA NEUROPATHOLOGICAIF9.32018-07-1135OAAI
Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 miceFASEB JOURNALIF4.22012-10-04272OA